Paper9706063
Single-dose pharmacokinetics of rifapentine in elderly men.
Keung AC and 2 others. Pharm Res, 1998. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Single-dose pharmacokinetics of rifapentine in elderly men. Papers, record 9706063. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9706063
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antitubercular Agents | Major topic |
| Rifampin | Major topic |
| Aged | |
| Aged, 80 and over | |
| Half-Life | |
| Humans | |
| Male | |
| Reference Values |
Source PubMed
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2155555 | Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis. | Am Rev Respir Dis | 1990 | https://conductscience.org/library/papers/2155555 | PubMed |
| 2 | 6262396 | Gastric emptying rate in the elderly: implications for drug therapy. | J Am Geriatr Soc | 1981 | https://conductscience.org/library/papers/6262396 | PubMed |
| 3 | 5459997 | Adult lean body mass declines with age: some longitudinal observations. | Metabolism | 1970 | https://conductscience.org/library/papers/5459997 | PubMed |
| 4 | 4627605 | Aging, total body potassium, fat-free mass, and cell mass in males and females between ages 18 and 85 years. | J Gerontol | 1972 | https://conductscience.org/library/papers/4627605 | PubMed |
| 5 | 728306 | Antibacterial activity in serum and urine following oral administration in man of DL473 (a cyclopentyl derivative of rifampicin) [proceedings]. | Br J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/728306 | PubMed |
| 6 | 6845400 | Pharmacokinetic studies of rifampicin in the elderly. | Ther Drug Monit | 1983 | https://conductscience.org/library/papers/6845400 | PubMed |
| 7 | 7791396 | Symposium on geriatrics--Part I: Drug prescribing for elderly patients. | Mayo Clin Proc | 1995 | https://conductscience.org/library/papers/7791396 | PubMed |
| 8 | 9698286 | Disposition and metabolism of 14C-rifapentine in healthy volunteers. | Drug Metab Dispos | 1998 | https://conductscience.org/library/papers/9698286 | PubMed |
| 9 | 2834842 | In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria. | Tubercle | 1987 | https://conductscience.org/library/papers/2834842 | PubMed |
| 10 | 4893850 | The aging gastrointestinal tract. | Am J Surg | 1969 | https://conductscience.org/library/papers/4893850 | PubMed |
| 11 | 6356275 | Rifampin: mechanisms of action and resistance. | Rev Infect Dis | 1983 | https://conductscience.org/library/papers/6356275 | PubMed |
| 12 | 8590563 | Epidemiology of tuberculosis in Europe. | Eur Respir J Suppl | 1995 | https://conductscience.org/library/papers/8590563 | PubMed |
| 13 | 2686883 | Clinical pharmacokinetic considerations in the elderly. An update. | Clin Pharmacokinet | 1989 | https://conductscience.org/library/papers/2686883 | PubMed |
| 14 | 1956210 | The disposition of antituberculous drugs in plasma of elderly patients. II. Isoniazid, rifampicin and pyrazinamide. | Methods Find Exp Clin Pharmacol | 1991 | https://conductscience.org/library/papers/1956210 | PubMed |
| 15 | 8335033 | Identification of populations at risk in drug testing and therapy: application to elderly patients. | Eur J Drug Metab Pharmacokinet | 1993 | https://conductscience.org/library/papers/8335033 | PubMed |
| 16 | 639902 | The effect of ageing on the biliary excretion of ouabain in the rat. | Exp Gerontol | 1978 | https://conductscience.org/library/papers/639902 | PubMed |
| 17 | 8785251 | The clinical pharmacokinetics of rifabutin. | Clin Infect Dis | 1996 | https://conductscience.org/library/papers/8785251 | PubMed |
| 18 | 2688002 | Tuberculosis in the elderly. | Semin Respir Infect | 1989 | https://conductscience.org/library/papers/2688002 | PubMed |
| 19 | 8064768 | Pharmacokinetics of drugs in the elderly. | J R Soc Med | 1994 | https://conductscience.org/library/papers/8064768 | PubMed |
| 20 | 2663734 | Pharmacokinetic and pharmacodynamic principles of drug therapy in old age. Part 1. | Int J Clin Pharmacol Ther Toxicol | 1989 | https://conductscience.org/library/papers/2663734 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39898756 | Comparative study on the bioavailability and bioequivalence of rifapentine capsules in humans. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39898756 | PubMed |
| 31591118 | A Pharmacology Perspective of Simultaneous Tuberculosis and Hepatitis C Treatment. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/31591118 | PubMed |
| 29066867 | Clinical and pharmacological hallmarks of rifapentine's use in diabetes patients with active and latent tuberculosis: do we know enough? | Drug Des Devel Ther | 2017 | https://conductscience.org/library/papers/29066867 | PubMed |
| 28242663 | Factors Influencing Tuberculosis Treatment Outcome in Adult Patients Treated with Thrice-Weekly Regimens in India. | Antimicrob Agents Chemother | 2017 | https://conductscience.org/library/papers/28242663 | PubMed |
| 27270284 | Physiologically Based Pharmacokinetic Model of Rifapentine and 25-Desacetyl Rifapentine Disposition in Humans. | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/27270284 | PubMed |
| 19075046 | New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19075046 | PubMed |
| 16251279 | Population pharmacokinetics of rifapentine and its primary desacetyl metabolite in South African tuberculosis patients. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/16251279 | PubMed |
| 10935428 | Treatment of tuberculous infection and disease in children: the North American perspective. | Paediatr Drugs | 1999 | https://conductscience.org/library/papers/10935428 | PubMed |
| 10722501 | Single-dose intrapulmonary pharmacokinetics of rifapentine in normal subjects. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10722501 | PubMed |
| 9806107 | Rifapentine. | Drugs | 1998 | https://conductscience.org/library/papers/9806107 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9706063
GET https://conductscience.org/api/papers/v1/9706063/references?page=2